⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PSTV News
PLUS THERAPEUTICS, Inc. Common Stock
Plus Therapeutics Receives Medicare Enrollment Approval for CNSide Diagnostic
globenewswire.com
PSTV
Plus Therapeutics Secures Blue Shield of California Coverage for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
globenewswire.com
PSTV
Plus Therapeutics Initiates Manufacturing Activities with SpectronRx Under a Master Services Agreement to Support GMP Pivotal Trial Readiness for REYOBIQ™
globenewswire.com
PSTV
Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
PSTV
Form 8-K
sec.gov
PSTV
Plus Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
globenewswire.com
PSTV
Plus Therapeutics Appoints Randy H. Goodman, PhD, MHA, as Vice President of Value Strategy & HEOR to Advance Market Access and Commercial Execution
globenewswire.com
PSTV
Form 8-K
sec.gov
PSTV
KPRX
Plus Therapeutics Appoints Eric J. Daniels, M.D., MBA, as Chief Development Officer to Advance Clinical Pipeline
globenewswire.com
PSTV
Form 8-K
sec.gov
PSTV